Driving reinvestment in R&D for antibiotics and advocating their responsible use

A new financing tool dedicated to research and development in infectious diseases has been launched by the European Commission and the European Investment Bank. This tool, called InnovFin Infectious Diseases, enables the European Investment Bank to provide between EUR 7.5m and EUR 75m to innovative players active in developing vaccines, drugs, medical and diagnostic devices, and research infrastructures for combating infectious diseases. Financing is aimed at projects that have passed the pre-clinical stage and for which clinical validation is needed for further development.